When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. J&J boosts heart device business in $13.1 billion Shockwave deal

   www.aol.com/news/johnson-johnson-buy-shockwave...

   (Reuters) -Johnson & Johnson on Friday agreed to buy Shockwave Medical in a deal valued at $13.1 billion including debt, as it builds its cardiac-health-centric medical devices business to help ...

3. J&J in talks to buy Shockwave Medical, WSJ reports - AOL

   www.aol.com/news/j-j-talks-buy-shockwave...

   When contacted for comment on the WSJ report, J&J and Shockwave Medical said they do not comment on rumors or speculation. ... the company acquired heart pump maker Abiomed for $16.6 billion.

4. J&J to pump another $13B into its MedTech business with ...

   www.aol.com/news/j-j-pump-another-13b-125626976.html

   J&J's Shockwave deal still needs approvals from regulators and shareholders. The companies expect to close the acquisition by the middle of this year. Shares of New Brunswick, New Jersey-based J&J ...

5. Johnson & Johnson - Wikipedia

   en.wikipedia.org/wiki/Johnson_&_Johnson

   Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange.

6. Ethicon - Wikipedia

   en.wikipedia.org/wiki/Ethicon

   In 2009, Ethicon acquired breast implant maker Mentor, [8] [9] and in 2010 it acquired ear, nose and throat technology company Acclarent. [10] In 2016, Ethicon acquired NeuWave Medical. [11] In 2013, J&J merged Ethicon Endo-Surgery back into Ethicon. [6] As of September 10, 2024, Ethicon began operating under the name Johnson & Johnson MedTech ...

7. Johnson & Johnson Vision - Wikipedia

   en.wikipedia.org/wiki/Johnson_&_Johnson_Vision

   In Jan. 16, 2007 AMO announced the acquisition of privately held WaveFront Sciences Inc., a provider of wavefront diagnostic systems for refractive surgery and medical research, for $20 million in cash. [7] AMO acquired Irvine-based IntraLase Corp. for $808 million in January 2007. [8]

8. Janssen Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Janssen_Pharmaceuticals

   In 1961, Janssen Pharmaceuticals was purchased by New Jersey–based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical ...

9. J&J to buy cancer therapy developer Ambrx for $2 billion - AOL

   www.aol.com/news/j-j-buy-cancer-therapy...

   J&J's acquisition is the latest deal announced in the space. J&J will pay $28 per share of Ambrx, which represents a premium of about 105% to the stock's last close. Ambrx is developing therapies ...